HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Postprocedural left ventricular aneurysm — Clinical Guidelines

Overview

Postprocedural left ventricular aneurysm (LV aneurysm) is a complication that arises following myocardial infarction or cardiac surgery, characterized by localized dilation and thinning of the ventricular wall. This condition can lead to significant hemodynamic instability, heart failure symptoms, and reduced cardiac output. It predominantly affects patients with a history of ischemic heart disease, particularly those who have undergone surgical interventions such as coronary artery bypass grafting or repairs for ventricular septal defects. Early recognition and appropriate management are crucial as delayed treatment can result in poor outcomes, including increased mortality and morbidity. Understanding the nuances of LV aneurysm management is essential for clinicians to optimize patient care and improve long-term prognosis 1 8 9.

Pathophysiology

The development of a left ventricular aneurysm typically follows a cascade of events initiated by myocardial infarction. Ischemia leads to necrosis of myocardial tissue, which subsequently undergoes remodeling characterized by thinning and dilation of the ventricular wall. This process is driven by extracellular matrix proteins, inflammatory cells, and proteolytic enzymes that degrade the structural integrity of the myocardium 1. The aneurysmal sac often contains non-contractile muscle, leading to dyskinesia and impaired cardiac function. Over time, this can result in regional wall motion abnormalities, reduced ejection fraction, and increased risk of arrhythmias and thromboembolic events 1 6. The geometry of the aneurysm—whether circular or rectangular—further influences contractile efficiency and overall cardiac performance, highlighting the importance of surgical techniques that aim to optimize ventricular shape and function 4.

Epidemiology

The incidence of postprocedural left ventricular aneurysms varies but is generally observed in a subset of patients who have experienced severe myocardial infarction or undergone complex cardiac surgeries. These aneurysms are more common in older populations, with a mean age ranging from the sixth to eighth decade 1 9. Males tend to be overrepresented, reflecting broader trends in ischemic heart disease prevalence. Geographic and socioeconomic factors can influence access to timely and advanced surgical interventions, thereby affecting incidence rates. Over time, advancements in surgical techniques and revascularization strategies have likely impacted the incidence and outcomes, though precise trends are not consistently reported across all studies 1 10.

Clinical Presentation

Patients with left ventricular aneurysms often present with symptoms indicative of heart failure, including dyspnea, fatigue, and exercise intolerance. Acute presentations may involve signs of hemodynamic instability such as hypotension, syncope, or signs of congestive heart failure like pulmonary edema. A palpable pulsatile mass in the precordium can sometimes be noted, particularly in cases of pseudoaneurysms. Red-flag features include sudden onset of severe chest pain, unexplained weight loss, and recurrent thromboembolic events, which warrant urgent evaluation 1 3 5.

Diagnosis

The diagnostic approach to left ventricular aneurysms involves a combination of clinical assessment, imaging modalities, and sometimes invasive hemodynamic monitoring. Key diagnostic criteria include:

Echocardiography: Essential for initial detection, showing localized wall thinning and aneurysmal sac formation. Doppler echocardiography can assess hemodynamics and detect any associated valvular dysfunction 1 3.

Cardiac MRI or CT: Provides detailed anatomical information, distinguishing true aneurysms from pseudoaneurysms and assessing the extent of myocardial involvement 3 4.

Coronary Angiography: Useful in evaluating coronary artery patency and identifying any residual ischemia or need for revascularization 1 8.

Electrocardiogram (ECG): May show signs of previous infarction or arrhythmias, supporting the diagnosis 1.

Differential Diagnosis:

Pseudoaneurysm: Distinguished by communication with the ventricular cavity, often seen in post-surgical or post-percutaneous interventions 3 5.

Ventricular Septal Defect (VSD): Echocardiography and angiography help differentiate by identifying a defect in the ventricular septum 1 8.

Aortic Aneurysm: Imaging studies clarify the location and nature of the aneurysm, distinguishing it from ventricular involvement 2.

Management

Surgical Repair

First-line Approach:

Endoventricular Patch Plasty (Dor Procedure): Recommended for optimal ventricular geometry restoration, improving contractile function 6 8 9.

- Specifics: Complete revascularization, patch placement to exclude non-contractile segments, potential mitral valve repair. - Contraindications: Severe comorbidities precluding major surgery, extensive calcification of the aneurysm 6.

Second-line Approach:

Linear Suture Repair: Considered when endoventricular techniques are not feasible.

- Specifics: Direct closure of the aneurysmal defect using sutures. - Contraindications: Limited efficacy in restoring ventricular shape and function compared to patch techniques 8.

Monitoring and Postoperative Care:

Regular echocardiographic follow-up to assess ventricular function and aneurysm healing.

Close monitoring for signs of infection, arrhythmias, and heart failure exacerbation 1 8.

Medical Management

Optimization of Heart Failure Therapy: Use of ACE inhibitors/ARBs, beta-blockers, diuretics, and aldosterone antagonists to manage symptoms and improve cardiac function 1.

Antithrombotic Therapy: Prophylactic anticoagulation to prevent thromboembolic events, especially in pseudoaneurysms 1 3.

Complications

Acute Complications: Hemodynamic instability, arrhythmias, acute heart failure exacerbation.

Long-term Complications: Recurrent aneurysm formation, progression to heart failure, increased risk of thromboembolism.

Management Triggers: Persistent symptoms, imaging evidence of aneurysm progression, or recurrent thromboembolic events warrant prompt referral to a cardiothoracic surgeon 1 3 5.

Prognosis & Follow-up

The prognosis for patients with left ventricular aneurysms varies based on the extent of myocardial damage, surgical technique, and postoperative management. Key prognostic indicators include preoperative ejection fraction, presence of comorbidities, and successful surgical repair. Recommended follow-up intervals typically include:

Short-term (3-6 months post-surgery): Regular echocardiograms and clinical assessments.

Long-term (annually): Continued monitoring of cardiac function, adherence to heart failure medications, and periodic imaging to assess aneurysm healing and ventricular remodeling 1 8.

Special Populations

Elderly Patients: Higher risk of complications; careful risk stratification and tailored surgical approaches are crucial 1 9.

Pediatrics: Rare but requires specialized pediatric cardiac surgical expertise; outcomes depend significantly on underlying etiology and extent of damage 1.

Comorbidities: Patients with diabetes, renal impairment, or severe lung disease may require more intensive perioperative management to optimize outcomes 1 8.

Key Recommendations

Surgical Repair with Endoventricular Patch Plasty: Preferred technique for optimal ventricular restoration and improved survival (Evidence: Strong 6 8 9).

Comprehensive Revascularization: Essential component of surgical repair to enhance myocardial perfusion and function (Evidence: Strong 1 8).

Postoperative Echocardiographic Monitoring: Regular follow-up to assess aneurysm healing and ventricular function (Evidence: Moderate 1 8).

Heart Failure Medication Optimization: Use of ACE inhibitors/ARBs, beta-blockers, and diuretics to manage symptoms and improve cardiac output (Evidence: Strong 1).

Prophylactic Anticoagulation: Recommended in pseudoaneurysms to prevent thromboembolic events (Evidence: Moderate 3).

Risk Stratification for Surgery: Essential in elderly patients to balance surgical risks and benefits (Evidence: Moderate 9).

Multidisciplinary Care Approach: Involving cardiologists, cardiothoracic surgeons, and heart failure specialists for comprehensive management (Evidence: Expert opinion).

Close Monitoring for Recurrent Aneurysm Formation: Regular imaging and clinical follow-up to detect early signs of recurrence (Evidence: Moderate 1).

Consideration of Concomitant Procedures: Mitral valve repair and coronary artery bypass grafting when indicated to address multiple pathologies simultaneously (Evidence: Moderate 1 8).

Tailored Postoperative Care Plan: Addressing specific comorbidities to minimize complications and enhance recovery (Evidence: Expert opinion).

References

1 Toker ME, Onk OA, Alsalehi S, Sunar H, Zeybek R, Balkanay M et al.. Posterobasal left ventricular aneurysms: surgical treatment and long-term outcomes. Texas Heart Institute journal 2013. link 2 Kim H, Lee S, Hwang D, Huh S, Yun WS, Kim HK. Prognostic impact of early type II endoleak detected 1 month after endovascular aneurysm repair on midterm outcomes in a two-center cohort. Journal of vascular surgery 2026. link 3 Kawashima M, Murakami H, Nomura Y, Tanaka H. Giant pseudoaneurysm that developed seven years after surgical repair of a postinfarction ventricular septal defect. General thoracic and cardiovascular surgery 2021. link 4 Adhyapak SM, Menon PG, Parachuri VR. Optimization of surgical ventricular restoration by in-silico simulations. Asian cardiovascular & thoracic annals 2014. link 5 Moharana MK, Agarwal S, Minhas HS, Pratap H, Satsangi DK. Delayed presentation of iatrogenic left ventricular pseudoaneurysm. Journal of cardiac surgery 2010. link 6 Sartipy U, Albåge A. Versatility of the endoventricular patch technique in repair of postinfarction left ventricular rupture. Singapore medical journal 2008. link 7 Proschek D, Proschek P, Hochmuth K, Balzer JO, Mack MG, Vogl TJ. False aneurysm of the left femoral artery and thrombosis of the left femoral vein after total hip arthroplasty. Archives of orthopaedic and trauma surgery 2006. link 8 Lundblad R, Abdelnoor M, Svennevig JL. Surgery for left ventricular aneurysm: early and late survival after simple linear repair and endoventricular patch plasty. The Journal of thoracic and cardiovascular surgery 2004. link 9 Tavakoli R, Bettex D, Weber A, Brunner H, Genoni M, Pretre R et al.. Repair of postinfarction dyskinetic LV aneurysm with either linear or patch technique. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2002. link00210-5) 10 Vural KM, Sener E, Ozatik MA, Taşdemir O, Bayazit K. Left ventricular aneurysm repair: an assessment of surgical treatment modalities. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1998. link00287-x) 11 Gott VL. C. Walton Lillehei and his trainees: one man's legacy to cardiothoracic surgery. The Journal of thoracic and cardiovascular surgery 1989. link

Postprocedural left ventricular aneurysm